Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to -$529586.0.

  • HealthLynked's Net Income towards Common Stockholders rose 6831.38% to -$529586.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 4606.4%. This contributed to the annual value of -$6.1 million for FY2024, which is 50575.59% down from last year.
  • As of Q3 2025, HealthLynked's Net Income towards Common Stockholders stood at -$529586.0, which was up 6831.38% from -$435385.0 recorded in Q2 2025.
  • HealthLynked's 5-year Net Income towards Common Stockholders high stood at $1.5 million for Q1 2023, and its period low was -$7.9 million during Q1 2021.
  • Its 5-year average for Net Income towards Common Stockholders is -$1.5 million, with a median of -$1.2 million in 2024.
  • In the last 5 years, HealthLynked's Net Income towards Common Stockholders plummeted by 126360.36% in 2021 and then soared by 21555.24% in 2023.
  • Over the past 5 years, HealthLynked's Net Income towards Common Stockholders (Quarter) stood at -$1.8 million in 2021, then crashed by 141.85% to -$4.4 million in 2022, then skyrocketed by 70.53% to -$1.3 million in 2023, then increased by 4.32% to -$1.2 million in 2024, then skyrocketed by 56.95% to -$529586.0 in 2025.
  • Its Net Income towards Common Stockholders stands at -$529586.0 for Q3 2025, versus -$435385.0 for Q2 2025 and -$617389.0 for Q1 2025.